Axordia Ltd

Axordia is a stem cell company with a unique portfolio of cell lines, cell differentiation and cell characterisation technologies. Human embryonic stem cells (HESCs) offer substantial opportunities in the drug discovery and toxicology arenas as well as the potential to cure chronic and degenerative diseases.

Axordia’s products will provide a significant asset to improve pharmaceutical company drug discovery in the short term and establish Axordia as a key player in the production of quality assured stem cell therapeutic technologies – including cells, assays and proliferating factors. The Axordia business model is designed to fully exploit the commercial potential of the fundamental scientific know-how and related intellectual property in a key centre of excellence.

For more information please visit

www.axordia.com